|
| Body parts | Microbiome metabolites | Inhibited bacteria | References |
|
| Right wing, body surface, entire body | (i) Bacteriophage | (i) Pseudomonas spp. | (i) Laziz et al. [22] |
| (ii) Antimicrobial peptide (AMP): mersacidin, subpeptin JM4-B, subtilosin A, sublancin, enterpco E-760, microcin L, microcin J25, colicin, lactocyclicin Q | (ii) E. coli | (ii) Claresta et al. [20]; Zhao et al. [34] |
| (iii) MRSA, Streptococcus pyogenes, S. agalactiae, and S. pneumoniae | (iii) Simons et al. [35] |
| (iv) S. aureus, S. faecalis, Salmonella sp., and Shigella flexneri | (iv) Yang et al. [36] |
| | (v) Enterococcus faecalis and Listeria monocytogenes | |
| | (vi) Yersinia spp., Campylobacter spp. Staphylococcus spp. Listeria monocytogenes | |
| | (vii) Pseudomonas aeruginosa | |
| | (viii) Lactoccocus spp. | |
|
| Hemolymph | (i) AMP: cecropin, defensins, Hf-1, MDAP-2, a thermal stable antimicrobial protein | S. aureus, S. epidermidis, and P. aeruginosa | (i) Liang et al. [37]; Wang et al. [38]; Dang et al. [39]; Hou et al. [10]; Pei et al. [40]; Hao et al. [41] |
| (ii) Lysozyme | | (ii) Kawasaki and Andoh [42] |
|
| Body extract | (i) The butanol fraction obtained from ethanol | (i) MRSA and VRE strains | (i) Park et al. [25] |
| (ii) Methanolic whole body extract: 1-lysophosphatidylethanolamine (C16:1) (1-LPE) | (ii) B. thuringiensis and Saccharomyces cerevisiae | (ii) Meylaers [24] |
|
| Cuticular lipid | Mixtures of alcohols | Rhodococcus equi, Candida lipolytica, C. tropicalis | (i) Gołêbiowski [14] |
|
| Digestive track | AMP: mersacidin, subpeptin JM4-B, subtilosin A, sublancin, microcin L, microcin J25, and colicin | (i) MRSA, Streptococcus pyogenes, S. agalactiae, and S. pneumoniae | (i) Simons et al. [35] |
| | (ii) S. aureus, S. faecalis, Salmonella sp., and Shigella flexneri | (ii) Yang et al. [36] |
| | (iii) Enterococcus faecalis and Listeria monocytogenes | |
| | (iv) E. coli, Salmonella enterica, Shigella spp., and Pseudomonas aeruginosa | |
|
